🟢 Icecure Medical is trading 5% up in pre-market with no clear catalyst identified

Icecure Medical is trading 5.26% higher at $1.70 in pre-market on October 1, 2026; no clear company-specific catalyst has been identified.

• Shares closed at $1.61 on September 30, following recent weakness.
• Its latest listed press release was the September 10 China regulatory approval; no newer announcement was listed through October 1.
• Broader market signals were mixed, with no established market-wide explanation for the rise.